CNO Financial Group (CNO)
(Delayed Data from NYSE)
$36.07 USD
-0.44 (-1.21%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $36.06 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$36.07 USD
-0.44 (-1.21%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $36.06 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Zacks News
MetLife (MET) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNO Financial (CNO) Earnings Expected to Grow: What to Know Ahead of Q3 Release
by Zacks Equity Research
CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is CNO Financial Group (CNO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
CNO Financial (CNO) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
CNO Financial (CNO) Gains 26% in a Year: More Room to Run?
by Zacks Equity Research
CNO Financial (CNO) is well-poised for growth on a diversified product portfolio, product launches and the prudent deployment of capital.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
CNO (CNO) Down 4.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why CNO Financial (CNO) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
CNO Financial (CNO) Unit Ties Up to Boost Advocacy Services
by Zacks Equity Research
CNO Financial's (CNO) unit, Optavise, collaborates with SentryHealth to bolster its portfolio of advocacy services and assure the well-being of its employers' workforce.
Why CNO Financial (CNO) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
CNO Financial's (CNO) Q2 Earnings Miss on Higher Expenses
by Zacks Equity Research
CNO Financial (CNO) expects 2023 EPS in the range of $2.65-$2.85, indicating a decline from the 2022 figure of $3.06.
CNO (CNO) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for CNO (CNO) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CNO Financial (CNO) Lags Q2 Earnings Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of -21.74% and 11.76%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Assurant (AIZ) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Assurant (AIZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate CNO Financial (CNO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Ageas (AGESY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Hold Is an Apt Strategy for EverQuote (EVER) Now
by Zacks Equity Research
EverQuote (EVER) stands to gain from the solid performance of automotive insurance vertical, higher consumer traffic and improved quote request volume.
EverQuote (EVER) Exits Health Business to Improve Efficiency
by Zacks Equity Research
EverQuote (EVER) streamlines its operations by exiting from the health insurance business.
Here's Why Radian Group (RDN) Stock is an Attractive Pick Now
by Zacks Equity Research
Radian Group (RDN) is well-poised to grow, driven by improved persistency, higher mortgage interest rates and a strong capital position.
Why You Should Add CNO Financial (CNO) to Your Portfolio Now
by Zacks Equity Research
CNO Financial's (CNO) focus on updating products and launching new ones per customer demand differentiates it from peers.
Are Investors Undervaluing Cigna Group (CI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MGIC Investment (MTG) Up 24% in a Year: Will the Rally Last?
by Zacks Equity Research
MGIC Investment (MTG) stock rallies on the back of higher insurance in force, favorable loss reserve development, new business rewriting and prudent capital deployment.
CNO Financial (CNO) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
AIG Closes Deal to Boost Personal Lines' Client Growth
by Zacks Equity Research
AIG teams up with Stone Point to offer advanced portfolio offerings and better serve high net worth and ultra high net worth clients.